Rodrigo Moreno-Salgado

Dr. Rodrigo Moreno-Salgado

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Rodrigo Vazquez-FriasRodrigo Vazquez-Frias
Rodrigo Vazquez-Frias
GVGustavo Varela-Fascinetto
Gustavo Varela-Fascinetto
CBCarlos Patricio Acosta Rodríguez Bueno
Carlos Patricio Acosta Rodríguez Bueno
ACAlejandra Consuelo
Alejandra Consuelo
AGAriel Alberto Carrillo Gutiérrez
Ariel Alberto Carrillo Gutiérrez
TBTania Barragán-Arévalo
Tania Barragán-Arévalo
Alagille syndrome (ALGS) is a multisystem disorder characterized by a paucity of intrahepatic bile ducts and cholestasis, often requiring liver transplantation before adulthood. Due to the lack of genotype–phenotype correlation, case series are essential to understand disease presentation and prognosis. Data on Mexican ALGS patients are limited. Therefore, we aimed to characterize a large series of Mexican patients by consolidating cases from major institutions and independent geneticists, with the goal of generating one of the most comprehensive cohorts in Latin America. We retrospectively analyzed clinical records of pediatric ALGS patients, focusing on demographics, clinical features, laboratory and imaging results, biopsy findings, and transplant status. Genetic testing was performed for all cases without prior molecular confirmation. We identified 52 ALGS cases over 13 years; 22 had available clinical records. Of these, only 6 had molecular confirmation at study onset, prompting genetic testing in the remaining 16. We identified six novel JAG1 variants and several previously unreported phenotypic features. A liver transplantation rate of 13% was observed in the cohort. This study represents the largest molecularly confirmed ALGS cohort in Mexico to date. Novel genetic and clinical findings expand the known spectrum of ALGS and emphasize the need for improved therapies, such as IBAT inhibitors, which may alleviate symptoms and reduce the need for transplantation.

15 April 2023 in Cancer Genetics
Verified
Journal Article
Closed access
Rodrigo Moreno-SalgadoRodrigo Moreno-Salgado
Rodrigo Moreno-Salgado
YRYanen Zaneli Rios-Lozano
Yanen Zaneli Rios-Lozano
ATAna Carolina Tamayo-Palacio
Ana Carolina Tamayo-Palacio
ACAna Idalia-Yepez Castillo
Ana Idalia-Yepez Castillo
MHMaría Fernanda Hidalgo-Martínez
María Fernanda Hidalgo-Martínez

26 January 2020 in The Journal of Gene Medicine
Verified
Journal Article
Closed access
PDF file
MMMirna Martínez‐Saucedo
Mirna Martínez‐Saucedo
COCarolina Ornelas‐Fuentes
Carolina Ornelas‐Fuentes
MDMark Dedden
Mark Dedden
RSRocío Sánchez‐Urbina
Rocío Sánchez‐Urbina
HDHéctor Díaz‐García
Héctor Díaz‐García
JGJavier Tadeo Granados-Riveron
Javier Tadeo Granados-Riveron

22 July 2025 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
HRHernández‐Carreto Raúl
Hernández‐Carreto Raúl
APAcosta‐Rodríguez‐Bueno Carlos Patricio
Acosta‐Rodríguez‐Bueno Carlos Patricio
BTBarragán‐Arevalo Tania
Barragán‐Arevalo Tania
RORuiz‐Robles Osiris
Ruiz‐Robles Osiris
VAValdés‐Ortega Esteban Alberto
Valdés‐Ortega Esteban Alberto
Rodrigo Moreno-SalgadoRodrigo Moreno-Salgado
Rodrigo Moreno-Salgado

1 January 2023 in Annals of Clinical and Medical Case Reports
Verified
Journal Article
Open access
GIGarcía-Herrera Ip
García-Herrera Ip
RARamírez-Urbina A
Ramírez-Urbina A
MCMedina-Ruiz Cd
Medina-Ruiz Cd
Rodrigo Moreno-SalgadoRodrigo Moreno-Salgado
Rodrigo Moreno-Salgado
ALAparicio-Vera LA
Aparicio-Vera LA